Retpositive Inc

RETPositive advances research on RET-positive oncogenedriven cancers to improve patient outcomes and quality of life. 1 Research Grant Funding LUNGevity collaboration. Provided a competitive grant to support biomedical research focused on RET-positive oncogenes accelerating discovery and potential clinical impact for patients with RET-driven disease. 2 Public Awareness & Education informational video. Produced and distributed an educational video highlighting the challenges faced by RET-positive patients and their caregivers improving awareness among patients families and clinicians. 3 Patient Community & Information Access RETpositive.org + moderated support group. Maintained RETpositive.org with up-to-date resources and moderated a private volunteer-run peer-support community to connect patients and caregivers with timely information and shared experience.

$25K from 3 funders · 4 grants · 2022–2024